<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33717">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02667665</url>
  </required_header>
  <id_info>
    <org_study_id>TRIAD1412</org_study_id>
    <nct_id>NCT02667665</nct_id>
  </id_info>
  <brief_title>Verification Study and Reactivity Study for the Validity of QuQu Scale</brief_title>
  <acronym>QuQu</acronym>
  <official_title>Verification Study and Reactivity Study for the Validity of a Novel Dementia Rating Scale &quot;QUick QUestion Scale&quot; for Alzheimer's Disease Dementia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Translational Research Informatics Center, Kobe, Hyogo, Japan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Daiichi Sankyo Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Translational Research Informatics Center, Kobe, Hyogo, Japan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Examine the construct validity, the test-retest reliability, the concurrent validity with
      the standard dementia rating scales and the reactivity of a novel dementia rating scale
      &quot;QuQu scale: QUick QUestion scale&quot; final for the evaluation of patients with Alzheimer's
      Disease Dementia and Mild Cognitive Impairment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>QuQu scale candidate</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Mini-Mental State Examination (MMSE)</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>NPI-Caregiver Distress. Scale(NPI-D)</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Disability Assessment for Dementia (DAD)</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical Dementia Rating</measure>
    <time_frame>12 weeks</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Alzheimer's Disease Dementia</condition>
  <condition>Cognitive Concern Without Dementia</condition>
  <arm_group>
    <arm_group_label>Alzheimer's Disease Dementia</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>non-Dementia</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Alzheimer's Disease Dementia and Mild Cognitive Impairment
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Alzheimer's Disease Dementia and patients with cognitive concern without Dementia

          2. Written Informed consent by each subject and/or a legal representative, and study
             informant. If the doctor decides that the patient has no trouble in understanding
             this study, the written informed consent of a legal representative may be exempted.
             If not, this study needs a written informed consent by a legal representative and the
             patient except the case where the consent is hardly obtained due to the progression
             of the disease.

        Exclusion Criteria:

          1. patients with other types of dementia (e.g. vascular dementia, Levy body dementia,
             frontotemporal dementia)

          2. patients with other diseases which cause secondary dementia prior to Alzheimer's
             Disease Dementia

          3. patients with other severe neurological disease or psychiatric disorder without
             Alzheimer's Disease Dementia

          4. patients with other medical conditions where the investigators determine that it is
             inappropriate for the subject of this study (e.g. inappropriate for the evaluation of
             dementia rating scale)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yu Nakamura, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Kagawa University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yu Nakamura, Professor</last_name>
    <phone>087-891-2167</phone>
    <email>yunaka@med.kagawa-u.ac.jp</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kagawa University School of Medicine</name>
      <address>
        <city>Kitagun</city>
        <state>Kagawa Prefecture</state>
        <zip>761-0793</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yu Nakamura, Professor</last_name>
      <phone>087-891-2167</phone>
      <email>yunaka@med.kagawa-u.ac.jp</email>
    </contact>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 13, 2016</lastchanged_date>
  <firstreceived_date>January 26, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Alzheimer's Disease Dementia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
